Trade Roche Holding AG (Participation) - ROGz CFD
Add to favourite- Summary
- Historical Data
Spread | 0.9 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.014959% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.007263% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | CHF | ||||||||
Margin | 5% | ||||||||
Stock exchange | Switzerland | ||||||||
Commission on trade | 0% |
Prev. Close | 218.8 |
Open | 221.1 |
1-Year Change | -21.18% |
Day's Range | 218.1 - 221.1 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 25, 2024 | 218.8 | -2.9 | -1.31% | 221.7 | 222.3 | 217.7 |
Apr 24, 2024 | 221.7 | -3.9 | -1.73% | 225.6 | 226.2 | 220.1 |
Apr 23, 2024 | 229.3 | 4.2 | 1.87% | 225.1 | 230.0 | 224.9 |
Apr 22, 2024 | 225.6 | 2.2 | 0.98% | 223.4 | 226.7 | 222.7 |
Apr 19, 2024 | 220.6 | 1.8 | 0.82% | 218.8 | 221.0 | 218.0 |
Apr 18, 2024 | 219.6 | 0.4 | 0.18% | 219.2 | 221.3 | 218.3 |
Apr 17, 2024 | 220.0 | 0.1 | 0.05% | 219.9 | 221.7 | 218.1 |
Apr 16, 2024 | 220.8 | -2.5 | -1.12% | 223.3 | 224.4 | 219.9 |
Apr 15, 2024 | 224.3 | -2.1 | -0.93% | 226.4 | 226.6 | 223.0 |
Apr 12, 2024 | 224.7 | 0.7 | 0.31% | 224.0 | 226.5 | 224.0 |
Apr 11, 2024 | 225.4 | 3.6 | 1.62% | 221.8 | 228.4 | 221.8 |
Apr 10, 2024 | 223.9 | 1.7 | 0.77% | 222.2 | 224.1 | 221.6 |
Apr 9, 2024 | 221.6 | 1.1 | 0.50% | 220.5 | 223.3 | 220.5 |
Apr 8, 2024 | 219.3 | 1.6 | 0.73% | 217.7 | 219.5 | 216.5 |
Apr 5, 2024 | 219.0 | -3.6 | -1.62% | 222.6 | 223.0 | 218.1 |
Apr 4, 2024 | 224.3 | -1.6 | -0.71% | 225.9 | 226.9 | 223.6 |
Apr 3, 2024 | 225.6 | -1.7 | -0.75% | 227.3 | 227.6 | 224.9 |
Apr 2, 2024 | 227.4 | -2.5 | -1.09% | 229.9 | 231.0 | 225.3 |
Mar 28, 2024 | 228.8 | 3.3 | 1.46% | 225.5 | 229.6 | 225.5 |
Mar 27, 2024 | 226.4 | -0.5 | -0.22% | 226.9 | 228.1 | 225.6 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Roche Company profile
About Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Roche Holding AG revenues increased 8% to SF62.8B. Net income decreased 3% to SF13.93B. Revenues reflect Diagnostics segment increase of 29% to SF17.76B, Chugai segment increase of 20% to SF4.51B, Rest of Europe segment increase of 16% to SF11.38B, Rest of Asia segment increase of 13% to SF9.75B, Germany segment increase of 29% to SF4.29B.
Equity composition
3 April 2001, 100 for 1 stock split.
Industry: | Pharmaceuticals (NEC) |
Grenzacherstrasse 124
BASEL
BASEL-STADT 4058
CH
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com